Página Nct de ensaios clínicos

Clinical Trial Results:
An Open-Label, Phase IIIb, Multi-Centre, Randomised, Parallel-Group Study to Investigate the Efficacy and Safety of Three Dosing Schedules of Subcutaneous Dynepo in Adult Patients with Anaemia Associated with Chronic Kidney Disease who are Pre-Dialysis or Require Peritoneal Dialysis or Haemodialysis.

Summary
EudraCT number
2006-002052-15
Trial protocol
GB   BE   AT   FR   DE   IT   LT   LV   HU  
Global completion date
31 Jul 2008

Paediatric regulatory details
Is the trial part of an agreed EMA paediatric investigation plan?
No
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006?
No
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006?
No

Results information
Results version number
v1(current)
This version publication date
12 Jul 2018
First version publication date
20 Dec 2014
Other versions
Summary report(s)
SPD490-301
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.
3
Se inscrever